Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
PULM — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

0.75

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

1.66

Target Price

10

Analyst Recom

1

Performance Q

30

Upside

-1,053.8%

Beta

1.91

Ticker: PULM



19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13PULM1.65N/AN/A0
2026-07-14PULM1.6N/AN/A0
2026-07-15PULM1.61N/AN/A0
2026-07-16PULM1.61N/AN/A0
2026-07-17PULM1.65N/AN/A0
2026-07-20PULM1.68N/AN/A0
2026-07-21PULM1.68N/AN/A0
2026-07-22PULM1.69N/AN/A0
2026-07-23PULM1.75N/AN/A0
2026-07-24PULM1.64N/AN/A0
2026-07-27PULM1.73N/AN/A0
2026-07-28PULM1.68N/AN/A0
2026-07-29PULM1.66N/AN/A0
2026-07-30PULM1.68N/AN/A0
2026-07-31PULM1.72N/AN/A0
2026-08-03PULM1.72N/AN/A0
2026-08-04PULM1.71N/AN/A0
2026-08-05PULM1.65N/AN/A0
2026-08-07PULM1.66N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1



20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13PULM1.65- - -
2026-07-14PULM1.61- - -
2026-07-15PULM1.57- - -
2026-07-16PULM1.61- - -
2026-07-17PULM1.69- - -
2026-07-20PULM1.64- - -
2026-07-21PULM1.69- - -
2026-07-22PULM1.68- - -
2026-07-23PULM1.75- - -
2026-07-24PULM1.70- - -
2026-07-27PULM1.71- - -
2026-07-28PULM1.71- - -
2026-07-29PULM1.68- - -
2026-07-30PULM1.64- - -
2026-07-31PULM1.71- - -4.34
2026-08-03PULM1.72- - -4.34
2026-08-04PULM1.72- - -4.34
2026-08-05PULM1.65- - -4.34
2026-08-06PULM1.67- - -4.34
2026-08-07PULM1.66- - -4.34
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1



20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-13PULM0-11.282.50
2026-07-14PULM0-11.282.50
2026-07-15PULM0-11.282.50
2026-07-16PULM0-11.282.50
2026-07-17PULM0-11.282.50
2026-07-20PULM0-11.282.50
2026-07-21PULM0-11.282.50
2026-07-22PULM0-11.282.50
2026-07-23PULM0-11.282.50
2026-07-24PULM0-11.282.50
2026-07-27PULM0-4.500.75
2026-07-28PULM0-4.500.75
2026-07-29PULM0-4.500.75
2026-07-30PULM0-4.500.75
2026-07-31PULM0-4.500.75
2026-08-03PULM0-4.420.75
2026-08-04PULM0-4.420.75
2026-08-05PULM0-4.420.75
2026-08-06PULM0-4.420.75
2026-08-07PULM0-4.420.75
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

-1.04

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-4.42

Beta

1.91

Average Sales Estimate Current Quarter

2

Average Sales Estimate Next Quarter

Fair Value

Quality Score

6

Growth Score

Sentiment Score

30

Actual DrawDown %

92

Max Drawdown 5-Year %

-94.1

Target Price

10

P/E

Forward P/E

PEG

P/S

P/B

2.34

P/Free Cash Flow

EPS

-1.24

Average EPS Est. Cur. Y​

-4.34

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.03

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ PULM Healthcare
$1.69
📉
Swing / Pullback
Buy the dip on strong trends
54 /100
WEAK
Trend
8/20
Pullback
21/25
Volume
11/15
Valuation
12/20
TP/AR
2/10
Options
0/10
RSI
52.6
Range 1M
31.9%
Sup Dist
2.2%
🚀
Momentum Growth
Ride accelerating trends
N/A
16 /100
WEAK
Momentum
5/25
Growth
8/30
Estimates
0/20
Inst/Vol
3/15
Options
0/10
EPS Yr
0%
EPS NY
0%
52W%
11.5%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +491.7% upside
Quality
2/30
Valuation
16/30
Growth
3/25
Stability
6/10
LT Trend
3/5
Upside
+491.7%
Quality
6
Click a card to see score breakdown Full Analysis →
PULM — P/E HistoricalBiotechnology
Pulmatrix, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 2
Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor compounds. The company was founded in 2003 and is headquartered in Framingham, Massachusetts.
PULM

Latest News

—
Caricamento notizie per PULM…
stock quote shares PULM – Pulmatrix Inc Stock Price stock today
news today PULM – Pulmatrix Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PULM – Pulmatrix Inc yahoo finance google finance
stock history PULM – Pulmatrix Inc invest stock market
stock prices PULM premarket after hours
ticker PULM fair value insiders trading